会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Method of producing polyhydroxyalkanoate
    • 聚羟基链烷酸酯的制备方法
    • US20060105440A1
    • 2006-05-18
    • US11237686
    • 2005-09-29
    • Koichi KinoshitaYoshifumi YanagidaFumio OsakadaYasuyoshi Ueda
    • Koichi KinoshitaYoshifumi YanagidaFumio OsakadaYasuyoshi Ueda
    • C12P7/62
    • C12P7/62C08G63/89
    • The present invention has its object to provide a method of producing PHA by extracting, separating, and purifying PHA from biomass containing PHA having an weight average molecular weight of more than 2,000,000, by which smooth stirring can be carried out during extraction and filterability of a residue becomes good to thereby efficiently produce PHA with good operability. In the present invention, PHA is extracted, separated, and purified from biomass by a method of producing polyhydroxyalkanoate by extracting and isolating polyhydroxyalkanoate by using an aprotic organic solvent from biomass containing polyhydroxyalkanoate having a weight average molecular weight of more than 2,000,000, which comprises decreasing the weight average molecular weight of the polyhydroxyalkanoate through any one of the following treatments: (a) the biomass is heated at 40 to 500° C. before addition of the aprotic organic solvent; (b) the biomass is heated at 40 to 500° C. before addition of the aprotic organic solvent, and is further heated at 40 to 200° C. in the aprotic organic solvent; (c) the biomass is heated at 40 to 500° C. before addition of the aprotic organic solvent, and is further heated at 40 to 200° C. in the aprotic organic solvent in the presence of water and/or an alcohol; (d) the biomass is not heated before addition of the aprotic organic solvent, but is heated at 40 to 200° C. in the aprotic organic solvent; and (e) the biomass is not heated before addition of the aprotic organic solvent, but is heated at 40 to 200° C. in the aprotic organic solvent in the presence of water and/or an alcohol.
    • 本发明的目的是提供一种通过从重均分子量大于2,000,000的PHA的生物质中提取,分离和纯化PHA来生产PHA的方法,通过该方法可以在提取过程中进行平稳的搅拌和过滤性 残留物变得良好,从而有效地产生具有良好可操作性的PHA。 在本发明中,通过使用含有重均分子量大于2,000,000的聚羟基链烷酸酯的生物质的非质子有机溶剂提取和分离聚羟基链烷酸酯的方法,从生物质中提取,分离和纯化PHA,其包括降低 通过以下任何一种处理,聚羟基链烷酸酯的重均分子量:(a)在加入非质子有机溶剂之前,将生物质在40-500℃下加热; (b)在加入非质子有机溶剂之前将生物质在40-500℃加热,并在非质子有机溶剂中在40〜200℃下进一步加热; (c)在加入非质子有机溶剂之前将生物质加热至40-500℃,并在水和/或醇存在下,在非质子有机溶剂中在40〜200℃下进一步加热; (d)在加入非质子有机溶剂之前,不加热生物质,但在非质子有机溶剂中在40〜200℃下加热生物质; 和(e)生物质在加入非质子有机溶剂之前不被加热,但在水和/或醇的存在下,在非质子传递的有机溶剂中在40-200℃下加热。
    • 7. 发明授权
    • Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid
    • 制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药理学上可接受的盐的方法
    • US06713628B2
    • 2004-03-30
    • US10295897
    • 2002-11-18
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • C07D20704
    • C07K5/0222C07K5/06026
    • There is provided a process for preparing a pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid which comprises condensing an amino acid and N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine.N-carboxyanhydride under basic condition, carrying out decarboxylation under between neutral and acidic condition to obtain N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid, and forming a pharmacologically acceptable salt thereof, wherein the production of a by-product (3): is suppressed by carrying out in an aqueous liquid a series of operations till formation of the pharmacologically acceptable salt or till isolation of the pharmacologically acceptable salt. The present invention enables to prepare the pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid having high quality, in a commercial scale with high yield and economical efficiency.
    • 提供了制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药学上可接受的盐的方法,其包括将氨基酸和N-(1(S) - 乙氧基羰基 - 3-苯基丙基)-L-丙氨酸N-羧酸酐,在中性和酸性条件下进行脱羧,得到N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸,和 形成其药理学上可接受的盐,其中通过在含水液体中进行一系列操作直到形成药理学上可接受的盐或直到药理学上可接受的盐的分离来抑制副产物(3)的产生。 本发明能够以高产率和经济效益以商业规模制备质量高的N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药理学上可接受的盐。
    • 9. 发明授权
    • Process for preparing pharmacologically acceptable salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid
    • 制备正((S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药学上可接受的盐的方法
    • US06518436B2
    • 2003-02-11
    • US09989186
    • 2001-11-21
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • Yasuyoshi UedaKoichi KinoshitaTadashi MoroshimaYoshifumi YanagidaYoshihide Fuse
    • C07D20704
    • C07K5/0222C07K5/06026
    • There is provided a process for preparing a pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid which comprises condensing an amino acid and N-(1(S) -ethoxycarbonyl-3-phenylpropyl)-L-alanine N-carboxy-anhydride under basic condition, carrying out decarboxylation under between neutral and acidic condition to obtain N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid, and forming a pharmacologically acceptable salt thereof, wherein the production of a by-product (3): is suppressed by carrying out in an aqueous liquid a series of operations till formation of the pharmacologically acceptable salt or till isolation of the pharmacologically acceptable salt. The present invention enables to prepare the pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid having high quality, in a commercial scale with high yield and economical efficiency.
    • 提供了制备N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药学上可接受的盐的方法,其包括将氨基酸和N-(1(S) - 乙氧基羰基 - 3-苯基丙基)-L-丙氨酸N-羧酸酐,在中性和酸性条件下进行脱羧,得到N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸, 并形成其药学上可接受的盐,其中通过在含水液体中进行一系列操作直至形成药理学上可接受的盐或直到药理学上可接受的盐的分离来抑制副产物(3)的产生。 本发明能够以高产率和经济效益以商业规模制备质量高的N-(1(S) - 乙氧基羰基-3-苯基丙基)-L-丙氨酰 - 氨基酸的药理学上可接受的盐。